Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Frequent inactivation of CDKN2A and rare mutation of TP53 in PCNSL.
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
Frequent inactivation of CDKN2A and rare mutation of TP53 in PCNSL.
Frequent inactivation of CDKN2A and rare mutation of TP53 in PCNSL. Brain Pathol. 1998 Apr; 8(2):263-76.
View in:
PubMed
subject areas
Aged
Central Nervous System Neoplasms
Cyclin-Dependent Kinase Inhibitor p16
Female
Gene Expression Regulation
Humans
Immunohistochemistry
Lymphoma, B-Cell
Lymphoma, T-Cell
Male
Middle Aged
Molecular Biology
Mutation
Tumor Suppressor Protein p53
authors with profiles
David N. Louis, M.D.